TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models

被引:0
|
作者
van Hummel, Annika [1 ]
Sabale, Miheer [1 ]
Przybyla, Magdalena [1 ]
van der Hoven, Julia [1 ]
Chan, Gabriella [1 ]
Feiten, Astrid F. [2 ]
Chung, Roger S. [3 ]
Ittner, Lars M. [1 ]
Ke, Yazi D. [1 ]
机构
[1] Macquarie Univ, Fac Med Hlth & Human Sci, Dementia Res Ctr, Macquarie Med Sch, Sydney, NSW, Australia
[2] Ludwig Maximilians Univ Munchen, Fac Med, Biomed Ctr BMC, Div Metab Biochem, D-81377 Munich, Germany
[3] Macquarie Univ, Fac Med Hlth & Human Sci, Ctr Motor Neuron Dis Res, Macquarie Med Sch, Sydney, NSW, Australia
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
amyotrophic lateral sclerosis; cyclin F; frontotemporal dementia; mouse models; TDP-43; ubiquitination; FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; MUTATIONS; GENE; EXPRESSION; ONSET; CCNF; ALS; NEURODEGENERATION; PHOSPHORYLATION;
D O I
10.1111/nan.12902
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: Amyotrophic lateral sclerosis (ALS) is characterised by a progressive loss of upper and lower motor neurons leading to muscle weakness and eventually death. Frontotemporal dementia (FTD) presents clinically with significant behavioural decline. Approximately 10% of cases have a known family history, and disease-linked mutations in multiple genes have been identified in FTD and ALS. More recently, ALS and FTD-linked variants have been identified in the CCNF gene, which accounts for an estimated 0.6% to over 3% of familial ALS cases.Methods: In this study, we developed the first mouse models expressing either wild-type (WT) human CCNF or its mutant pathogenic variant S621G to recapitulate key clinical and neuropathological features of ALS and FTD linked to CCNF disease variants. We expressed human CCNF WT or CCNFS621G throughout the murine brain by intracranial delivery of adeno-associated virus (AAV) to achieve widespread delivery via somatic brain transgenesis.Results: These mice developed behavioural abnormalities, similar to the clinical symptoms of FTD patients, as early as 3 months of age, including hyperactivity and disinhibition, which progressively deteriorated to include memory deficits by 8 months of age. Brains of mutant CCNF_S621G mice displayed an accumulation of ubiquitinated proteins with elevated levels of phosphorylated TDP-43 present in both CCNF_WT and mutant CCNF_S621G mice. We also investigated the effects of CCNF expression on interaction targets of CCNF and found elevated levels of insoluble splicing factor proline and glutamine-rich (SFPQ). Furthermore, cytoplasmic TDP-43 inclusions were found in both CCNF_WT and mutant CCNF_S621G mice, recapitulating the key hallmark of FTD/ALS pathology.Conclusions: In summary, CCNF expression in mice reproduces clinical presentations of ALS, including functional deficits and TDP-43 neuropathology with altered CCNF-mediated pathways contributing to the pathology observed.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD
    Matthew A. White
    Eosu Kim
    Amanda Duffy
    Robert Adalbert
    Benjamin U. Phillips
    Owen M. Peters
    Jodie Stephenson
    Sujeong Yang
    Francesca Massenzio
    Ziqiang Lin
    Simon Andrews
    Anne Segonds-Pichon
    Jake Metterville
    Lisa M. Saksida
    Richard Mead
    Richard R Ribchester
    Youssef Barhomi
    Thomas Serre
    Michael P. Coleman
    Justin R. Fallon
    Timothy J. Bussey
    Robert H. Brown
    Jemeen Sreedharan
    Nature Neuroscience, 2018, 21 : 552 - 563
  • [42] TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD
    White, Matthew A.
    Kim, Eosu
    Duffy, Amanda
    Adalbert, Robert
    Phillips, Benjamin U.
    Peters, Owen M.
    Stephenson, Jodie
    Yang, Sujeong
    Massenzio, Francesca
    Lin, Ziqiang
    Andrews, Simon
    Segonds-Pichon, Anne
    Metterville, Jake
    Saksida, Lisa M.
    Mead, Richard
    Ribchester, Richard R.
    Barhomi, Youssef
    Serre, Thomas
    Coleman, Michael P.
    Fallon, Justin
    Bussey, Timothy J.
    Brown, Robert H.
    Sreedharan, Jemeen
    NATURE NEUROSCIENCE, 2018, 21 (04) : 552 - +
  • [43] Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS
    Yazi D. Ke
    Annika van Hummel
    Claire H. Stevens
    Amadeus Gladbach
    Stefania Ippati
    Mian Bi
    Wei S. Lee
    Sarah Krüger
    Julia van der Hoven
    Alexander Volkerling
    Andre Bongers
    Glenda Halliday
    Nikolas K. Haass
    Matthew Kiernan
    Fabien Delerue
    Lars M. Ittner
    Acta Neuropathologica, 2015, 130 : 661 - 678
  • [44] Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS
    Ke, Yazi D.
    van Hummel, Annika
    Stevens, Claire H.
    Gladbach, Amadeus
    Ippati, Stefania
    Bi, Mian
    Lee, Wei S.
    Krueger, Sarah
    van der Hoven, Julia
    Volkerling, Alexander
    Bongers, Andre
    Halliday, Glenda
    Haass, Nikolas K.
    Kiernan, Matthew
    Delerue, Fabien
    Ittner, Lars M.
    ACTA NEUROPATHOLOGICA, 2015, 130 (05) : 661 - 678
  • [45] Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS
    Shan, Xiaoyang
    Vocadlo, David
    Krieger, Charles
    NEUROSCIENCE LETTERS, 2009, 458 (02) : 70 - 74
  • [46] Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD
    Luan, Wei
    Wright, Amanda L. L.
    Brown-Wright, Heledd
    Le, Sheng
    San Gil, Rebecca
    Martin, Lidia Madrid San
    Ling, Karen
    Jafar-Nejad, Paymaan
    Rigo, Frank
    Walker, Adam K. K.
    MOLECULAR PSYCHIATRY, 2023, 28 (06) : 2445 - 2461
  • [47] Mitochondrial analysis in wild-type TDP-43 transgenic mice mimicking sporadic inclusion body myositis
    Zhang, Z.
    Yamashita, S.
    Tawara, N.
    Kawakami, K.
    Doki, T.
    Matsuo, Y.
    Zhang, X.
    Maeda, Y.
    Ando, Y.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S154 - S154
  • [48] Publisher Correction: TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD
    Matthew A. White
    Eosu Kim
    Amanda Duffy
    Robert Adalbert
    Benjamin U. Phillips
    Owen M. Peters
    Jodie Stephenson
    Sujeong Yang
    Francesca Massenzio
    Ziqiang Lin
    Simon Andrews
    Anne Segonds-Pichon
    Jake Metterville
    Lisa M. Saksida
    Richard Mead
    Richard R. Ribchester
    Youssef Barhomi
    Thomas Serre
    Michael P. Coleman
    Justin R. Fallon
    Timothy J. Bussey
    Robert H. Brown
    Jemeen Sreedharan
    Nature Neuroscience, 2018, 21 : 1138 - 1138
  • [49] Early activation of cellular stress and death pathways caused by cytoplasmic TDP-43 in the rNLS8 mouse model of ALS and FTD
    Wei Luan
    Amanda L. Wright
    Heledd Brown-Wright
    Sheng Le
    Rebecca San Gil
    Lidia Madrid San Martin
    Karen Ling
    Paymaan Jafar-Nejad
    Frank Rigo
    Adam K. Walker
    Molecular Psychiatry, 2023, 28 : 2445 - 2461
  • [50] Muscle-dominant wild-type TDP-43 expression induces myopathological changes featuring tubular aggregates and TDP-43-positive inclusions
    Tawara, Nozomu
    Yamashita, Satoshi
    Kawakami, Kensuke
    Kurashige, Takashi
    Zhang, Ziwei
    Tasaki, Masayoshi
    Yamamoto, Yasuhiro
    Nishikami, Tomo
    Doki, Tsukasa
    Zhang, Xiao
    Matsuo, Yoshimasa
    Kimura, En
    Tawara, Akie
    Maeda, Yasushi
    Hauschka, Stephen D.
    Maruyama, Hirofumi
    Ando, Yukio
    EXPERIMENTAL NEUROLOGY, 2018, 309 : 169 - 180